Plea In SC Seeks Examination Of AstraZeneca's Covishield Vaccine's Side Effects oneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oneindia.com Daily Mail and Mail on Sunday newspapers.
A plea has been filed seeking setting up of an expert medical panel to study and assess the possible risk factors associated with the Astrazeneca s Covishield vaccine, which was one of two vaccines administered in India against Covid-19. Advocate Vishal Tiwari in his fresh application said that AstraZeneca had accepted a link between the vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS).
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
AstraZeneca, the manufacturer of the Covishield vaccine, has admitted in a UK court that the vaccine can cause side effects such as blood clots. This revelation has raised concerns, especially since over half of India's population has been vaccinated with Covishield., India News - Times Now
AstraZeneca, following global outrage over the side effects of the vaccine, said on Tuesday that the benefits of the vaccine “far outweigh” the risks of “extremely rare” potential side effects. - Benefits Of Covishield COVID Vaccine Far Outweigh Extremely Rare Potential Side Effects: AstraZeneca